SC 36602 (actisomide)

structure given in first source

Also Known As:

actisomide; 4-(2-(bis(1-methylethyl)amino)ethyl)-4,4a,5,6,7,8-hexahydro-1-methyl-4-phenyl-3H-pyrido(1,2-c)pyrimidin-3-one; SC-36602; 3H-Pyrido(1,2-c)pyrimidin-3-one, 4-(2-(bis(1-methylethyl)amino)ethyl)-4,4a,5,6,7,8-hexahydro-1-methyl-4-phenyl-, trans-(+-)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidinones: 71
      - SC 36602: 1

Related Diseases

Cardiac Arrhythmias (Arrythmia)

02/01/1989 - "The antiarrhythmic effectiveness of a new class I agent, SC-36602, was evaluated in two canine models of ventricular arrhythmia. "
02/01/1989 - "Efficacy and plasma concentrations of SC-36602 in canine models of ventricular arrhythmia."
02/01/1989 - "In a Harris coronary ligation-induced arrhythmia model, SC-36602 significantly reduced ectopic rate at doses of 8 mg/kg i.v. and 15, 20 and 30 mg/kg per os. "
02/01/1989 - "In a ouabain-induced arrhythmia model, a 9 mg/kg i.v. dose of SC-36602 had a sustained (greater than or equal to 60 min) antiarrhythmic effect. "

Related Drugs and Biologics

1.	Ouabain (G Strophanthin)

Related Therapies and Procedures

1.	Ligation